IGC PHARMA INC (IGC) Top Institutional Shareholders
IGC PHARMA INC (IGC) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $1.13M in IGC holdings during the latest filing period.
Geode Capital Management, Llc is currently the largest disclosed institutional shareholder of IGC tracked by InsiderSet, reporting ownership valued at approximately $274,440 in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $287,660.969, representing an estimated gain of +4.82% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 91% of the total disclosed IGC value among the investors covered in this analysis. Major shareholders include Geode Capital Management, Llc, Vanguard Capital Management Llc, Blackrock, Inc., and several other long-term asset managers with concentrated positions in IGC PHARMA INC (IGC).
This page ranks the largest institutional IGC shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
35
Total Reported Value
$1.13M
Largest Holder
Geode Capital Management, Llc
Largest Position
$274,440
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
39
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Geode Capital Management, Llc | 0.00% | 1,043,384 | $274,440 | $287,661 | +$13,221 | +4.82% | |
| Vanguard Capital Management Llc | 0.00% | 718,436 | $188,949 | $198,073 | +$9,124 | +4.83% | |
| Blackrock, Inc. | 0.00% | 703,798 | $185,099 | $194,037 | +$8,938 | +4.83% | |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 483,975 | $127,285 | $133,432 | +$6,147 | +4.83% |
| Vanguard Fiduciary Trust Co | 0.00% | 415,888 | $109,379 | $114,660 | +$5,281 | +4.83% | |
| State Street Corp | 0.00% | 200,799 | $52,810 | $55,360 | +$2,550 | +4.83% | |
| Susquehanna International Group, Llp | 0.00% | 122,595 | $32,242 | $33,799 | +$1,557 | +4.83% | |
| Northern Trust Corp | 0.00% | 113,407 | $29,826 | $31,266 | +$1,440 | +4.83% | |
| Lawood & Co | 0.02% | 75,000 | $19,725 | $20,678 | +$953 | +4.83% | |
| Goldman Sachs Group Inc | 0.00% | 65,541 | $17,237 | $18,070 | +$833 | +4.83% | |
| Dearborn Partners Llc | 0.00% | 59,401 | $15,622 | $16,377 | +$755 | +4.83% | |
| Xtx Topco Ltd | 0.00% | 50,648 | $13,320 | $13,964 | +$644 | +4.83% | |
| Fisher Asset Management, Llc | 0.00% | 43,400 | $11,414 | $11,965 | +$551 | +4.83% | |
| Truist Financial Corp | 0.00% | 36,667 | $9,643 | $10,109 | +$466 | +4.83% | |
| Morgan Stanley | 0.00% | 35,118 | $9,236 | $9,682 | +$446 | +4.83% | |
| Commonwealth Equity Services, Llc | 0.00% | 33,848 | $8,900 | $9,332 | +$432 | +4.85% | |
| Tower Research Capital Llc (Trc) | 0.00% | 21,049 | $5,536 | $5,803 | +$267 | +4.83% | |
| T3 Companies, Llc | 0.01% | 20,000 | $5,260 | $5,514 | +$254 | +4.83% | |
| Vanguard Global Advisers, Llc | 0.00% | 14,944 | $3,930 | $4,120 | +$190 | +4.84% | |
| Hightower Advisors, Llc | 0.00% | 10,000 | $2,630 | $2,757 | +$127 | +4.83% | |
| Schneider Downs Wealth Management Advisors, Lp | 0.00% | 10,000 | $2,630 | $2,757 | +$127 | +4.83% | |
| Wealthcare Advisory Partners Llc | 0.00% | 10,000 | $2,630 | $2,757 | +$127 | +4.83% | |
| Ubs Group Ag | 0.00% | 8,097 | $2,129 | $2,232 | +$103 | +4.85% | |
| Trask Adam Roland | 0.00% | 5,000 | $1,315 | $1,379 | +$64 | +4.83% | |
| Group One Trading Llc | 0.00% | 3,762 | $989 | $1,037 | +$48 | +4.87% | |
| Geneos Wealth Management Inc. | 0.00% | 3,000 | $780 | $827 | +$47 | +6.04% | |
| Cwm, Llc | 0.00% | 1,000 | $263 | $276 | +$13 | +4.83% | |
| Caitlin John, Llc | 0.00% | 200 | $53 | $55 | +$2 | +4.04% | |
| Farther Finance Advisors, Llc | 0.00% | 101 | $27 | $28 | +$1 | +3.13% | |
| Hurley Capital, Llc | 0.00% | 100 | $26 | $28 | +$2 | +6.04% | |
| Dhjj Financial Advisors, Ltd. | 0.00% | 80 | $22 | $22 | +$0 | +0.25% | |
| Napier Financial, Llc | 0.00% | 58 | $15 | $16 | +$1 | +6.60% | |
| Virtu Financial Llc | 0.00% | 23,233 | $6 | $6,405 | +$6,399 | +106655.64% | |
| Johnson Financial Group, Inc. | 0.00% | 1 | $1 | $0 | -$1 | -72.43% | |
| Triumph Capital Management | 0.00% | 2 | $1 | $1 | -$0 | -44.86% |
Frequently asked questions about IGC
Who owns the most IGC stock?
The largest holders of IGC are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for IGC PHARMA INC (IGC).
Is IGC widely held by superinvestors?
Many widely followed stocks like IGC appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly IGC is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.